SenesTech, Inc. (NASDAQ:SNES) Files An 8-K Results of Operations and Financial ConditionItem 2.02
On March 29, 2018, SenesTech, Inc. (the “Company”) announced its financial results for the fourth quarter and year-ended December 31, 2017 and held a live webcast conference call on that date to review those results. A transcript of the conference call is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
The information in Exhibit 99.1 shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933 (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
|Item 9.01||Financial Statements and Exhibits.|
The following exhibits are being furnished herewith:
SenesTech, Inc. ExhibitEX-99.1 2 s109560_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 SenesTech,…To view the full exhibit click
About SenesTech, Inc. (NASDAQ:SNES)
SenesTech, Inc. is a platform biotechnology company. The Company is engaged in developing a technology for managing animal pest populations through fertility control. Its approach is designed to manage food security and manage infrastructure damage, disease outbreaks, environmental contamination and other costs associated with rodent infestations. Its fertility control product candidate, ContraPest, will be marketed for use in controlling rat populations. ContraPest targets the reproductive capabilities of rodents by inducing the gradual loss of eggs in female rodents and disruption of sperm in male rodents, resulting in contraception that can progress to sterility in both females and males. The Company applies its technology to manage rats in urban and agricultural settings. It has a pipeline of fertility control and animal health products, which include ContraPest, Plant-based fertility control, Feral animal fertility control, Boar taint, and Non-Surgical Spay and Neutering.